🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Dina Ramadane

Stock Analyst at Bank of America Securities

(2.59)
# 2,983
Out of 5,144 analysts
36
Total ratings
38.1%
Success rate
4.9%
Average return

Stocks Rated by Dina Ramadane

ProKidney
Nov 13, 2026
Reiterated: Sell
Price Target: n/a
Current: $1.10
Upside: -
Immunovant
Nov 9, 2026
Reiterated: Buy
Price Target: $45 → $46
Current: $33.21
Upside: +38.51%
Vera Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.20
Upside: -
Biohaven
Oct 30, 2026
Reiterated: Sell
Price Target: n/a
Current: $13.24
Upside: -
Amylyx Pharmaceuticals
May 7, 2026
Reiterated: Buy
Price Target: $22
Current: $27.52
Upside: -20.06%